State Board of Administration of Florida Retirement System grew its position in Hill-Rom Holdings, Inc. (NYSE:HRC) by 0.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 85,337 shares of the medical technology company’s stock after purchasing an additional 510 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Hill-Rom were worth $9,034,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Securian Asset Management Inc lifted its stake in shares of Hill-Rom by 1.2% in the 4th quarter. Securian Asset Management Inc now owns 8,231 shares of the medical technology company’s stock valued at $729,000 after acquiring an additional 100 shares during the last quarter. Mastrapasqua Asset Management Inc. lifted its position in shares of Hill-Rom by 0.7% during the 4th quarter. Mastrapasqua Asset Management Inc. now owns 14,830 shares of the medical technology company’s stock worth $1,313,000 after buying an additional 105 shares in the last quarter. Johanson Financial Advisors Inc. increased its stake in shares of Hill-Rom by 4.8% during the 4th quarter. Johanson Financial Advisors Inc. now owns 2,437 shares of the medical technology company’s stock worth $217,000 after purchasing an additional 111 shares during the last quarter. Avitas Wealth Management LLC increased its stake in shares of Hill-Rom by 0.5% during the 1st quarter. Avitas Wealth Management LLC now owns 22,829 shares of the medical technology company’s stock worth $2,417,000 after purchasing an additional 119 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Hill-Rom by 4.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,400 shares of the medical technology company’s stock worth $390,000 after purchasing an additional 189 shares during the last quarter. 84.76% of the stock is currently owned by institutional investors.
HRC has been the subject of a number of recent research reports. Zacks Investment Research lowered shares of Hill-Rom from a “hold” rating to a “sell” rating in a research note on Thursday, February 21st. Needham & Company LLC reiterated a “buy” rating and issued a $116.00 price objective on shares of Hill-Rom in a research note on Monday, March 11th. ValuEngine lowered shares of Hill-Rom from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Finally, Barclays lifted their price objective on shares of Hill-Rom from $103.00 to $108.00 and gave the company an “equal weight” rating in a research note on Monday, April 15th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $109.88.
Hill-Rom (NYSE:HRC) last released its quarterly earnings results on Friday, April 26th. The medical technology company reported $1.14 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.03. The firm had revenue of $714.20 million during the quarter, compared to analyst estimates of $705.59 million. Hill-Rom had a net margin of 7.93% and a return on equity of 21.30%. The business’s revenue for the quarter was up .5% on a year-over-year basis. During the same period in the previous year, the business earned $1.05 EPS. On average, analysts expect that Hill-Rom Holdings, Inc. will post 5.05 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Friday, June 21st will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, June 20th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.87%. Hill-Rom’s dividend payout ratio (DPR) is currently 17.68%.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Featured Article: Swap
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.